Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)

Corcept Therapeutics' Current Taxes history spans 2 years, with the latest figure at $728000.0 for Q1 2018.

  • For Q1 2018, Current Taxes changed N/A year-over-year to $728000.0; the TTM value through Mar 2018 reached $728000.0, changed N/A, while the annual FY2017 figure was $66000.0, N/A changed from the prior year.
  • Current Taxes for Q1 2018 was $728000.0 at Corcept Therapeutics, up from $66000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $728000.0 in Q1 2018 and bottomed at $66000.0 in Q4 2017.